Daniel Associates

Drug Discovery Services Market by Process (Target Selection, Hit-to-Lead Identification, Lead Optimization), Type (Medicinal Chemistry, Biology Services, DMPK), Drug Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, Neurology) & Region – Global Forecast to 2023

  • The Drug Discovery Services market was valued at USD XX Million in 2017 and is estimated to reach USD XX Million by 2023, at a CAGR of XX% during the forecast period. The base year used for this study is 2017, and the forecast period considered is between 2018 and 2023.

    The objectives of the study are as follows:

    • To define, describe, and forecast the Drug Discovery Services market segmented on the basis of by Process (Target Selection, Hit-to-Lead Identification, Lead Optimization), Type (Medicinal Chemistry, Biology Services, DMPK), Drug Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, Neurology)
    • To forecast the market size in terms of value for various segments with respect to four main regions: North America, Europe, APAC, and RoW
    • To provide detailed information regarding the major factors influencing the growth of the Drug Discovery Services market (drivers, restraints, opportunities, and industry-specific challenges)
    • To provide a detailed overview of the value chain in the Drug Discovery Services market and analyze the market trends with Porter’s five forces analysis
    • To analyze the opportunities in the market for various stakeholders by identifying the high-growth segments of the Drug Discovery Services market
    • To strategically profile the key players and comprehensively analyze their market position in terms of ranking and core competencies, along with detailing the competitive landscape for the market leaders
    • To analyze competitive developments such as new product launches and developments; agreements and contracts; mergers and acquisitions; and expansions in the global Drug Discovery Services market

    The years considered for the study are:

    Base Year – 2017         Estimated Year – 2018         Forecast Period – 2023

    For company profiles in the report, 2017 has been considered as the base year. In certain cases, wherein information is unavailable for the base year, the years prior to it have been considered.

    Market Segmentation,

    Drug Discovery Services market,

    By Process

    Target Selection

    Target Validation

    Hit-to-lead Identification

    Lead Optimization

    Candidate Validation

    Drug Discovery Services market,

    By Type

    Medicinal Chemistry

    Biology Services

    Drug Metabolism and Pharmacokinetics (DMPK)

    Drug Discovery Services market,

    By Drug Type

    Small Molecules

    Biologics

    Drug Discovery Services market,

    By Therapeutic Area

    Oncology

    Neurology

    Cardiovascular Diseases

    Respiratory Diseases

    Diabetes

    Drug Discovery Services market,

    By Region

    North America

    Europe

    Asia Pacific

    Rest of the World (RoW)

  • Table of Contents

    1 Introduction

    2 Research Methodologies

    3 Executive Summaries

    4 Premium Insights
        4.1 Drug Discovery Services Market Overview
        4.2 Drug Discovery Services Market, By Process
    4.3 Drug Discovery Services Market, By Type
    4.4 Drug Discovery Services Market, By Drug Type
    4.5 Drug Discovery Services Market, By Therapeutic Area
    4.6 Drug Discovery Services Market, By Region

    5 Market Overview
        5.1 Introduction
        5.2 Market Dynamics
               5.2.1 Drivers
               5.2.2 Restraints
               5.2.3 Opportunities
               5.2.4 Burning Issues

    6 Drug Discovery Services Market, By Process
        6.1 Introduction
        6.2 Target Selection
        6.3 Target Validation
        6.4 Hit-To-Lead Identification
        6.5 Lead Optimization
        6.6 Candidate Validation

    7 Drug Discovery Services Market, By Type
        7.1 Introduction
        7.2 Medicinal Chemistry
        7.3 Biology Services
        7.4 Drug Metabolism and Pharmacokinetics (DMPK)

    8 Drug Discovery Services Market, By Drug Type
        8.1 Introduction
        8.2 Small Molecules
        8.3 Biologics

    9 Drug Discovery Services Market, By Therapeutic Area
        9.1 Introduction
        9.2 Oncology
        9.3 Neurology
        9.4 Cardiovascular Diseases

        9.5 Respiratory Diseases
        9.6 Diabetes
        9.7 Other Therapeutic Areas

    10 Drug Discovery Services Market, By Region
         10.1 Introduction
         10.2 North America
         10.3 Europe
         10.4 Asia Pacific (APAC)
         10.5 Rest of the World (RoW)

    11 Competitive Landscapes

    12 Company Profiles
         (Business Overview, Products & Services, Financials, Key Developments)*
         12.1 Thermo Fisher Scientific
         12.2 Merck
         12.3 GE Healthcare
         12.4 Albany Molecular Research, Inc. (AMRI)
         12.5 Charles River Laboratories International
         12.6 Evotec
         12.7 Pharmaceutical Product Development, LLC. (Ppd)
         12.8 Jubilant Biopsy
         12.9 Covance
         12.10 Genscript Biotech Corporation
         12.11 Erigena Discovery Technologies
         12.12 Wuxi Apptec
         12.13 Syngene

    *Details Might Not Be Captured in Case of Unlisted Companies.

     (List of Tables & Figures Included)



  • Select User License